Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 159.9 SEK -0.93% Market Closed
Market Cap: 12.7B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Capital Expenditures Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Capital Expenditures
-kr163m
CAGR 3-Years
-37%
CAGR 5-Years
-31%
CAGR 10-Years
-17%
AddLife AB
STO:ALIF B
Capital Expenditures
-kr308m
CAGR 3-Years
-49%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Capital Expenditures
-kr291.2m
CAGR 3-Years
-30%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Capital Expenditures
-kr57.8m
CAGR 3-Years
-22%
CAGR 5-Years
-50%
CAGR 10-Years
-21%
M
Magle Chemoswed Holding AB
STO:MAGLE
Capital Expenditures
-kr15.1m
CAGR 3-Years
-24%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Biotage AB's Capital Expenditures?
Capital Expenditures
-163m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Capital Expenditures amounts to -163m SEK.

What is Biotage AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%

Over the last year, the Capital Expenditures growth was -101%. The average annual Capital Expenditures growth rates for Biotage AB have been -37% over the past three years , -31% over the past five years , and -17% over the past ten years .

Back to Top